206 related articles for article (PubMed ID: 37189453)
1. Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies.
He Y; Gong F; Jin T; Liu Q; Fang H; Chen Y; Wang G; Chu PK; Wu Z; Ostrikov KK
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189453
[TBL] [Abstract][Full Text] [Related]
2. Cold atmospheric pressure plasma treatment combined with starvation increases autophagy and apoptosis in melanoma in vitro and in vivo.
Golpour M; Alimohammadi M; Sohbatzadeh F; Fattahi S; Bekeschus S; Rafiei A
Exp Dermatol; 2022 Jul; 31(7):1016-1028. PubMed ID: 35181947
[TBL] [Abstract][Full Text] [Related]
3. Trehalose enhanced cold atmospheric plasma-mediated cancer treatment.
Cao X; Fang T; Chen M; Ning T; Li J; Siegel PM; Park M; Chen Z; Chen G
Biomaterials; 2024 Sep; 309():122582. PubMed ID: 38678699
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8
Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H
Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in human myeloid leukemia cells by remote exposure of resistive barrier cold plasma.
Thiyagarajan M; Anderson H; Gonzales XF
Biotechnol Bioeng; 2014 Mar; 111(3):565-74. PubMed ID: 24022746
[TBL] [Abstract][Full Text] [Related]
6. Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer.
Shi Y; Fu Y; Zhang X; Zhao G; Yao Y; Guo Y; Ma G; Bai S; Li H
Cancer Immunol Immunother; 2021 Jan; 70(1):61-73. PubMed ID: 32632663
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
Juneja VR; McGuire KA; Manguso RT; LaFleur MW; Collins N; Haining WN; Freeman GJ; Sharpe AH
J Exp Med; 2017 Apr; 214(4):895-904. PubMed ID: 28302645
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
[TBL] [Abstract][Full Text] [Related]
9. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
10. Stromal Cell PD-L1 Inhibits CD8
O'Malley G; Treacy O; Lynch K; Naicker SD; Leonard NA; Lohan P; Dunne PD; Ritter T; Egan LJ; Ryan AE
Cancer Immunol Res; 2018 Nov; 6(11):1426-1441. PubMed ID: 30228206
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer.
Jung JM; Yoon HK; Kim SY; Yun MR; Kim GH; Lee WJ; Lee MW; Chang SE; Won CH
Molecules; 2023 May; 28(10):. PubMed ID: 37241912
[TBL] [Abstract][Full Text] [Related]
12. PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.
Kwak SY; Lee S; Han HD; Chang S; Kim KP; Ahn HJ
Mol Pharm; 2019 Dec; 16(12):4940-4953. PubMed ID: 31651174
[TBL] [Abstract][Full Text] [Related]
13. Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment.
Fang T; Cao X; Shen B; Chen Z; Chen G
Biomaterials; 2023 Sep; 300():122189. PubMed ID: 37307777
[TBL] [Abstract][Full Text] [Related]
14. Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent manner.
Muramatsu T; Noguchi T; Sugiyama D; Kanada Y; Fujimaki K; Ito S; Gotoh M; Nishikawa H
Int Immunol; 2021 Jan; 33(1):39-48. PubMed ID: 32729901
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model.
Song CH; Kim N; Nam RH; Choi SI; Jang JY; Kim JW; Na HY; Lee HN
Cancer Lett; 2022 Sep; 543():215780. PubMed ID: 35690286
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches.
Terefinko D; Dzimitrowicz A; Bielawska-Pohl A; Pohl P; Klimczak A; Jamroz P
Toxicol In Vitro; 2024 Jun; 98():105846. PubMed ID: 38754599
[TBL] [Abstract][Full Text] [Related]
17. COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes.
Cecil DL; Gad EA; Corulli LR; Drovetto N; Lubet RA; Disis ML
Cancer Prev Res (Phila); 2022 Apr; 15(4):225-231. PubMed ID: 34987061
[TBL] [Abstract][Full Text] [Related]
18. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with
Qin S; Yu Y; Guan H; Yang Y; Sun F; Sun Y; Zhu J; Xing L; Yu J; Sun X
Aging (Albany NY); 2021 Apr; 13(9):13006-13022. PubMed ID: 33910164
[TBL] [Abstract][Full Text] [Related]
19. Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway.
Adhikari M; Kaushik N; Ghimire B; Adhikari B; Baboota S; Al-Khedhairy AA; Wahab R; Lee SJ; Kaushik NK; Choi EH
Cell Commun Signal; 2019 May; 17(1):52. PubMed ID: 31126298
[TBL] [Abstract][Full Text] [Related]
20. Use of cold atmospheric plasma in the treatment of cancer.
Babington P; Rajjoub K; Canady J; Siu A; Keidar M; Sherman JH
Biointerphases; 2015 Jun; 10(2):029403. PubMed ID: 25791295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
